Carlyle director Rubenstein donates and sells 625K shares

Carlyle Group Inc. director David M. Rubenstein reported major share movements dated December 10, 2025.

Rhea-AI Filing Summary

Carlyle Group Inc. director David M. Rubenstein reported major share movements dated December 10, 2025. He made a charitable gift of 625,000 shares of Carlyle common stock, reported at a price of $0, and separately sold another 625,000 shares at $56.55 per share.

After these transactions, Rubenstein directly beneficially owned 27,999,644 shares of Carlyle common stock. The activity is reported on a Form 4 for one reporting person in his role as a director of Carlyle Group Inc.

Insider Trade Summary

Net Seller: 625,000 shares

Net Sell 2 txns

Insider Rubenstein David M.

Role Director

Sold 625,000 shs ($35.34M)

Type	Security	Shares	Price	Value
Gift	Common Stock	625,000	$0.00	$0.00
Sale	Common Stock	625,000	$56.55	$35.34M

Holdings After Transaction: Common Stock — 27,999,644 shares (Direct)

Footnotes (1)

1. F1. Reflects a charitable donation by the Reporting Person.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What insider transactions did Carlyle Group Inc. (CG) director David M. Rubenstein report?

David M. Rubenstein reported two transactions in Carlyle Group Inc. common stock on December 10, 2025: a charitable donation of 625,000 shares and a separate sale of 625,000 shares.

How many Carlyle Group Inc. (CG) shares did David M. Rubenstein donate to charity?

He donated 625,000 shares of Carlyle Group Inc. common stock, identified in the report with transaction code G, and described as a charitable donation.

At what price did David M. Rubenstein sell Carlyle Group Inc. (CG) shares on December 10, 2025?

Rubenstein sold 625,000 shares of Carlyle Group Inc. common stock at a price of $56.55 per share on December 10, 2025.

How many Carlyle Group Inc. (CG) shares did David M. Rubenstein hold after these transactions?

Following the reported donation and sale, David M. Rubenstein directly beneficially owned 27,999,644 shares of Carlyle Group Inc. common stock.

What is David M. Rubenstein’s relationship to Carlyle Group Inc. (CG) in this report?

In this report, David M. Rubenstein is identified as a director of Carlyle Group Inc., and the Form 4 is filed by one reporting person.

Which SEC form was used to disclose David M. Rubenstein’s Carlyle (CG) share transactions?

The transactions were disclosed on Form 4, which reports changes in the beneficial ownership of equity securities by company insiders.

AI-generated analysis. How Rhea-AI works. Not financial advice.

Form 4 Insider Transactions: What Each Field Means →

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 12/12/2025 - 05:35 PM EST Learn about SEC filing dates

SEC Form 4

FORM 4

UNITED STATES SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549

STATEMENT OF CHANGES IN BENEFICIAL OWNERSHIP

Filed pursuant to Section 16(a) of the Securities Exchange Act of 1934
or Section 30(h) of the Investment Company Act of 1940

OMB APPROVAL

OMB Number:			3235-0287
Estimated average burden
hours per response:			0.5

Check this box if no longer subject to Section 16. Form 4 or Form 5 obligations may continue. See Instruction 1(b).

Check this box to indicate that a transaction was made pursuant to a contract, instruction or written plan for the purchase or sale of equity securities of the issuer that is intended to satisfy the affirmative defense conditions of Rule 10b5-1(c). See Instruction 10.

1. Name and Address of Reporting Person^*

Rubenstein David M.

(Last) (First) (Middle)

1001 PENNSYLVANIA AVENUE, NW

(Street)

WASHINGTON DC 20004

(City) (State) (Zip)

2. Issuer Name and Ticker or Trading Symbol
Carlyle Group Inc. [ CG ]

5. Relationship of Reporting Person(s) to Issuer
(Check all applicable)

X	Director		10% Owner
	Officer (give title below)		Other (specify below)

3. Date of Earliest Transaction (Month/Day/Year)
12/10/2025

4. If Amendment, Date of Original Filed (Month/Day/Year)

6. Individual or Joint/Group Filing (Check Applicable Line)

X	Form filed by One Reporting Person
	Form filed by More than One Reporting Person

Table I - Non-Derivative Securities Acquired, Disposed of, or Beneficially Owned
1. Title of Security (Instr. 3)	2. Transaction Date (Month/Day/Year)	2A. Deemed Execution Date, if any (Month/Day/Year)	3. Transaction Code (Instr. 8)		4. Securities Acquired (A) or Disposed Of (D) (Instr. 3, 4 and 5)			5. Amount of Securities Beneficially Owned Following Reported Transaction(s) (Instr. 3 and 4)	6. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	7. Nature of Indirect Beneficial Ownership (Instr. 4)
			Code	V	Amount	(A) or (D)	Price
Common Stock	12/10/2025		G(1)		625,000	D	$0	28,624,644	D
Common Stock	12/10/2025		S		625,000	D	$56.55	27,999,644	D

Table II - Derivative Securities Acquired, Disposed of, or Beneficially Owned (e.g., puts, calls, warrants, options, convertible securities)
1. Title of Derivative Security (Instr. 3)	2. Conversion or Exercise Price of Derivative Security	3. Transaction Date (Month/Day/Year)	3A. Deemed Execution Date, if any (Month/Day/Year)	4. Transaction Code (Instr. 8)		5. Number of Derivative Securities Acquired (A) or Disposed of (D) (Instr. 3, 4 and 5)		6. Date Exercisable and Expiration Date (Month/Day/Year)		7. Title and Amount of Securities Underlying Derivative Security (Instr. 3 and 4)		8. Price of Derivative Security (Instr. 5)	9. Number of derivative Securities Beneficially Owned Following Reported Transaction(s) (Instr. 4)	10. Ownership Form: Direct (D) or Indirect (I) (Instr. 4)	11. Nature of Indirect Beneficial Ownership (Instr. 4)
				Code	V	(A)	(D)	Date Exercisable	Expiration Date	Title	Amount or Number of Shares

Explanation of Responses:

1. Reflects a charitable donation by the Reporting Person.

Remarks:

	/s/ Anne K. Frederick by power of attorney for David M. Rubenstein	12/12/2025
	** Signature of Reporting Person	Date
Reminder: Report on a separate line for each class of securities beneficially owned directly or indirectly.
* If the form is filed by more than one reporting person, see Instruction 4 (b)(v).
** Intentional misstatements or omissions of facts constitute Federal Criminal Violations See 18 U.S.C. 1001 and 15 U.S.C. 78ff(a).
Note: File three copies of this Form, one of which must be manually signed. If space is insufficient, see Instruction 6 for procedure.
Persons who respond to the collection of information contained in this form are not required to respond unless the form displays a currently valid OMB Number.